Ameritas Investment Partners’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,585
| Closed | -$4.78K | – | 3302 |
|
|
2023
Q1 | $4.78K | Hold |
2,585
| – | – | ﹤0.01% | 2870 |
|
|
2022
Q4 | $2.92K | Hold |
2,585
| – | – | ﹤0.01% | 2987 |
|
|
2022
Q3 | $6K | Hold |
2,585
| – | – | ﹤0.01% | 2914 |
|
|
2022
Q2 | $7K | Hold |
2,585
| – | – | ﹤0.01% | 2928 |
|
|
2022
Q1 | $18K | Hold |
2,585
| – | – | ﹤0.01% | 2612 |
|
|
2021
Q4 | $22K | Hold |
2,585
| – | – | ﹤0.01% | 2612 |
|
|
2021
Q3 | $19K | Hold |
2,585
| – | – | ﹤0.01% | 2743 |
|
|
2021
Q2 | $18K | Buy |
2,585
+1,352
| +110% | +$9.41K | ﹤0.01% | 2801 |
|
|
2021
Q1 | $13K | Hold |
1,233
| – | – | ﹤0.01% | 2758 |
|
|
2020
Q4 | $9K | Hold |
1,233
| – | – | ﹤0.01% | 2855 |
|
|
2020
Q3 | $10K | Hold |
1,233
| – | – | ﹤0.01% | 2737 |
|
|
2020
Q2 | $9K | Hold |
1,233
| – | – | ﹤0.01% | 2795 |
|
|
2020
Q1 | $6K | Hold |
1,233
| – | – | ﹤0.01% | 2784 |
|
|
2019
Q4 | $11K | Hold |
1,233
| – | – | ﹤0.01% | 2719 |
|
|
2019
Q3 | $4K | Hold |
1,233
| – | – | ﹤0.01% | 2967 |
|
|
2019
Q2 | $6K | Hold |
1,233
| – | – | ﹤0.01% | 2934 |
|
|
2019
Q1 | $8K | Hold |
1,233
| – | – | ﹤0.01% | 2779 |
|
|
2018
Q4 | $4K | Hold |
1,233
| – | – | ﹤0.01% | 2897 |
|
|
2018
Q3 | $8K | Hold |
1,233
| – | – | ﹤0.01% | 2901 |
|
|
2018
Q2 | $9K | Hold |
1,233
| – | – | ﹤0.01% | 2872 |
|
|
2018
Q1 | $28K | Hold |
1,233
| – | – | ﹤0.01% | 2250 |
|
|
2017
Q4 | $16K | Buy |
1,233
+613
| +99% | +$7.96K | ﹤0.01% | 2564 |
|
|
2017
Q3 | $10K | Hold |
620
| – | – | ﹤0.01% | 2787 |
|
|
2017
Q2 | $9K | Hold |
620
| – | – | ﹤0.01% | 2849 |
|
|
2017
Q1 | $14K | Buy |
+620
| New | +$14K | ﹤0.01% | 2580 |
|